News
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.
1d
Zacks Investment Research on MSNHere is What to Know Beyond Why Newmont Corporation (NEM) is a Trending StockNewmont Corporation (NEM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Lockheed (LMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
1d
Zacks Investment Research on MSNShould You Buy Newmont Stock After a 39% Rally in 6 Months?Newmont Corporation’s NEM shares have rallied 39.2% over the past six months, thanks to a spike in gold prices resulting from ...
COLUMBUS, Ohio (AP) — COLUMBUS, Ohio (AP) — Huntington Bancshares Inc. (HBAN) on Friday reported net income of $536 million in its second quarter. The bank, based in Columbus, Ohio, said it had ...
American Express expects full-year earnings to be $15 to $15.50 per share. American Express shares have risen slightly more ...
Regions Financial Corp. (RF) on Friday reported second-quarter earnings of $563 million. The Birmingham, Alabama-based bank ...
DETROIT — DETROIT — Ally Financial Inc. (ALLY) on Friday reported second-quarter net income of $352 million. On a per-share basis, the Detroit-based company said it had net income of $1.04. Earnings, ...
SEATTLE (AP) — SEATTLE (AP) — WaFd, Inc (WAFD) on Thursday reported fiscal third-quarter net income of $62 million. The bank, based in Seattle, said it had earnings of 73 cents per share. The results ...
Shares in Elevance Health dipped slightly premarket as the insurer reported $1.7 billion in profit for the second quarter of 2025, falling short of Wall Street analysts' expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results